Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $2.19 | Prev. Close $2.19 | Circuit Range N/A |
Day Range $2.19 - $2.19 | Year Range $2.16 - $21.00 | Volume 195 |
Average Traded $2.19 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $2.19 | $2.19 | +10.33% |
05-Feb-26 | $1.99 | $1.99 | -8.10% |
04-Feb-26 | $2.16 | $2.16 | -9.24% |
03-Feb-26 | $2.40 | $2.38 | -0.83% |
02-Feb-26 | $2.44 | $2.40 | +1.27% |
30-Jan-26 | $2.35 | $2.37 | -11.24% |
28-Jan-26 | $2.61 | $2.67 | -4.30% |